Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research

Wim J.R. Rietdijk; Sarah Dräger; Henrik Endeman; Birgit C.P. Koch

doi:10.1093/cid/ciad215

Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research

Wim J.R. Rietdijk^*
, Sarah Dräger
, Henrik Endeman
, Birgit C.P. Koch

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	663-664
Number of pages	2
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	77
Issue number	4
DOIs	https://doi.org/10.1093/cid/ciad215
Publication status	Published - 15 Aug 2023

Bibliographical note

Funding Information:
Financial support . This work was supported by the Dutch Organization for Health Research and Development (ZonMw) (grant number 848017008). Sarah Dräger was supported by the “Research Fund of the University of Basel for Excellent Junior Researchers” (grant number 3MS1093). The funders of the study had no role in writing of the study.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciad215

Cite this

@article{af516f43a46040868e4a6b7a980a5449,

title = "Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research",

author = "Rietdijk, \{Wim J.R.\} and Sarah Dr{\"a}ger and Henrik Endeman and Koch, \{Birgit C.P.\}",

note = "Funding Information: Financial support . This work was supported by the Dutch Organization for Health Research and Development (ZonMw) (grant number 848017008). Sarah Dr{\"a}ger was supported by the “Research Fund of the University of Basel for Excellent Junior Researchers” (grant number 3MS1093). The funders of the study had no role in writing of the study.",

year = "2023",

month = aug,

day = "15",

doi = "10.1093/cid/ciad215",

language = "English",

volume = "77",

pages = "663--664",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "4",

}

Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research. / Rietdijk, Wim J.R.; Dräger, Sarah ; Endeman, Henrik et al.
In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, No. 4, 15.08.2023, p. 663-664.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients

T2 - Learnings for Future Research

AU - Rietdijk, Wim J.R.

AU - Dräger, Sarah

AU - Endeman, Henrik

AU - Koch, Birgit C.P.

N1 - Funding Information: Financial support . This work was supported by the Dutch Organization for Health Research and Development (ZonMw) (grant number 848017008). Sarah Dräger was supported by the “Research Fund of the University of Basel for Excellent Junior Researchers” (grant number 3MS1093). The funders of the study had no role in writing of the study.

PY - 2023/8/15

Y1 - 2023/8/15

UR - https://www.scopus.com/pages/publications/85168789875

U2 - 10.1093/cid/ciad215

DO - 10.1093/cid/ciad215

M3 - Article

C2 - 37040603

AN - SCOPUS:85168789875

SN - 1058-4838

VL - 77

SP - 663

EP - 664

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

IS - 4

ER -

Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this